Quarterly Financial Data - Effects of the Restatement on the Condensed Consolidated Balance Sheet (Parenthetical) (Details) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Oct. 08, 2021
Common stock par value	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01		$ 0.01
Common stock share authorized	300,000,000	300,000,000	300,000,000	300,000,000	300,000,000	300,000,000	300,000,000	300,000,000		300,000,000
Common stock share issued	83,738,974	83,469,426	83,449,565	83,220,392	78,684,107	77,990,290	77,451,087	77,362,681
Common stock shares, outstanding	82,825,455	82,555,907	82,536,046	82,306,873	77,770,588	77,076,771	76,537,568	76,449,162
Treasury stock share issued	913,519	913,519	913,519	913,519	913,519	913,519	913,519	913,519
Allowance for doubtful accounts	$ 1,339	$ 934	$ 1,706	$ 1,816	$ 1,688	$ 1,990	$ 1,234	$ 1,310	$ 1,032
Other long-term liabilities	1,048	1,467	1,842	1,523	1,628	907	905	3,123
Accumulated deficit	(123,646)	(101,323)	(90,172)	(76,924)	(66,112)	(27,633)	(19,086)	(10,304)
Inventories, net	90,046	89,128	81,501	68,191	61,288	54,861	51,502	43,185
Adjustments
Other long-term liabilities								605
Accumulated deficit	(8,016)	(5,252)	(2,433)	(83)	1,677	1,393	216	(605)
Inventories, net	(8,016)	(5,252)	(3,724)	(983)	340	90
Adjustments | Interest Rate Swap
Other assets			1,291	900	1,337	1,303	414
Other long-term liabilities								605
Accumulated deficit			1,291	900	1,337	1,303	414	$ (605)
Adjustments | Inventory Treatment
Accumulated deficit	(8,016)	(5,252)	(3,724)	(983)	340	90	(198)
Inventories, net	$ (8,016)	$ (5,252)	$ (3,724)	$ (983)	$ 340	$ 90	$ (198)